Barbara K. Rimer, DrPHChairDean and Alumni Distinguished Professor
UNC Gillings School of Global Public HealthDr. Rimer was appointed to the President's Cancer Panel by President Barack Obama in 2011. Dr. Rimer's work in the cancer field has guided national research, practice, and policy for more than 20 years. Her research has contributed to the evidence base in a number of cancer-related areas, including informed decision making, long-term maintenance of behavior changes, adherence to cancer prevention and early detection practices, and dissemination and implementation of evidence-based interventions.Until 2015, Dr. Rimer served as Vice-Chair of the Task Force on Community Preventive Services at the Centers for Disease Control and Prevention. She was the first woman and behavioral scientist to chair the NCI's National Cancer Advisory Board. She has received numerous awards, including the 2004 Healthtrac Foundation Award for Health Education and the 2013 American Cancer Society's Medal of Honor.Dr. Rimer received a BA and an MPH from the University of Michigan and a DrPH from the Johns Hopkins School of Hygiene and Public Health.
The Panel accomplishes its mission by identifying high-priority topics for which actionable recommendations can be made, convening meetings with key experts and stakeholders to develop an understanding of the problems, challenges, opportunities, and potential solutions and then framing possible recommendations, including actions that should be taken by relevant organizations. Ultimately, following substantial input, the Panel submits a report to the President of the United States.
The Panel communicates its findings using a variety of tools—including print and web-based reports, social media, and presentations to a range of organizations. While reports are to the President, they are also for the larger group of stakeholders, public and private, that form the National Cancer Program as well as other partner organizations. Together, these organizations and others can make a positive difference in accelerating progress against cancer.
National Cancer Program